Regulus Therapeutics
RGLS
#6949
Rank
โ‚น50.75 B
Marketcap
โ‚น733.07
Share price
0.00%
Change (1 day)
469.51%
Change (1 year)

Earnings for Regulus Therapeutics (RGLS)

Earnings in 2025 (TTM): -โ‚น4.02 Billion

According to Regulus Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚น4.16 Billion a decrease over its 2023 earnings that were of -โ‚น2.65 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regulus Therapeutics from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น4.02 Billion-3.34%
2024 -โ‚น4.16 Billion56.97%
2023 -โ‚น2.65 Billion6.51%
2022 -โ‚น2.49 Billion2.53%
2021 -โ‚น2.43 Billion93.59%
2020 -โ‚น1.26 Billion-15.41%
2019 -โ‚น1.48 Billion-64.46%
2018 -โ‚น4.16 Billion-33.26%
2017 -โ‚น6.24 Billion-13.98%
2016 -โ‚น7.25 Billion44.77%
2015 -โ‚น5.01 Billion-1.63%
2014 -โ‚น5.09 Billion203.6%
2013 -โ‚น1.68 Billion8.65%
2012 -โ‚น1.55 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
GlaxoSmithKline
GSK
โ‚น837.53 B-19,756.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
โ‚น817.53 B-19,287.12%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚น171.04 B-4,114.42%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.175 T-27,699.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alnylam Pharmaceuticals
ALNY
โ‚น11.70 B-374.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚น9.8 Billion 129.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น721.65 B-17,036.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚น10.57 Billion 148.06%๐Ÿ‡บ๐Ÿ‡ธ USA